MALIGNANT NEOPLASM PROGRESSION

This adverse event was reported 67429 times

These drugs are most commonly taken by patients reporting MALIGNANT NEOPLASM PROGRESSION:

# Drug Count
0 NIVOLUMAB 7723
1 PEMBROLIZUMAB 5256
2 ENZALUTAMIDE 4780
3 EVEROLIMUS 3950
4 CARBOPLATIN 3442
5 IPILIMUMAB 2888
6 CAPECITABINE 2778
7 LETROZOLE 2656
8 FULVESTRANT 2483
9 PACLITAXEL 2384
See all common drugs associated with MALIGNANT NEOPLASM PROGRESSION

MALIGNANT NEOPLASM PROGRESSION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 AFATINIB 1487 0.2658
1 GEFITINIB 1517 0.1896
2 CERITINIB 380 0.1853
3 PRALATREXATE 82 0.1667
4 OLAPARIB 1221 0.1428
5 PEMBROLIZUMAB 5256 0.1422
6 RAMUCIRUMAB 594 0.1414
7 FULVESTRANT 2483 0.1282
8 STREPTOZOCIN 18 0.1277
9 OSIMERTINIB 1654 0.1271
See all drugs enriched for association with MALIGNANT NEOPLASM PROGRESSION